Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with ...

GSK is part of a global health care company committed to making a positive impact on the health of people around the world.

Bonum Therapeutics, a biotechnology company that is using innovative technology for conditional activation of biologics to ...

Mar Vista Investment Partners, LLC, an investment management company, released the “Strategic Growth Strategy” third quarter ...

"This is an exciting time to be joining Tonix as it prepares to receive an FDA decision on its NDA for TNX-102 SL for the ...

Spero Therapeutics (SPRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju ...

The global pneumonia therapeutics market is experiencing robust growth, driven by factors such as increasing healthcare expenditure, growing geriatric population, and rising investments in research ...

The Income Tax Authorities had raised a tax demand of Rs 962.75 crore (including an interest of Rs 329.33 crore) on the company, related to its deal with GlaxoSmithKline. Nazara has expanded into ...

On the heels of similar deals in the U.S. and the EU, the U.K. is filling up its coffers with doses of bird flu immunizations ...

Last week, the immuno-oncology specialist revealed that part of the new setup will include CDMO services, as it will produce ...

The FDA has accepted a biologics license application for Blenrep plus bortezomib or pomalidomide for patients with relapsed ...

The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.